| Registered or registration-pending trademarks of the QIAGEN Group: |
| QIAGEN®, QIA®, QIAamp®, QIAcard™, QIAcube®, QIAEX®, QIAexpress®, QIAGEN Quality™, QIApack™, QIAplex®, QIAprep®, QIAquick®, QIAsymphony®, QIAwell®, QIAxcel™, QIAzol®, AllPrep®, Allprotector®, artus®, BioRobot®, BioSprint®, cador™, Catrimox®, CompactPrep®, CoralLoad™, digene®, DirectPrep®, DNeasy®, DoubleTag®, DyeEx®, EASYartus®, EasyXpress®, EasyXtal®, Effectene®, EndoFree®, EpiTect®, EZ1®, FastLane®, FlexiGene®, FlexiTube™, GelPilot®, GeneGlobe®, Gentra®, HiPerFect™, HiSpeed®, HotStarTaq®, Hybrid Capture®, InhibitEX®, LabelStar®, LiquiChip®, LyseBlue®, MagAttract®, Mass·Spec·Focus®, Mass·Spec·Turbo®, MinElute®, NeXtal®, Oligotex®, Omniscript®, PlasmidAmp™, PolyFect®, ProofStart®, PSQ®,
Puregene®, Pyrosequencing®, Q-Solution®, Qproteome™, QuantiFast®, Quantiscript®, QuantiProbe®, QuantiTect®, Rapid Capture®, RCAT®, R.E.A.L.®, REPLI-g®, ResPlex™, RNAiFect®, RNAprotect®, RNeasy®, Sensiscript®, SPOC®, StaphPlex™, SuperFect®, T-Script®, TissueRuptor®, TopTaq®, TransMessenger®, TurboCapture™, TurboFilter®, Type-it™, UltraSens®.
|
| Disclaimers |
|
Registered names, trademarks, etc. used in the QIAGEN website, even when
not specifically marked as such, are not to be considered unprotected
by law.
External links on this web site are provided only for the convenience
of QIAGEN web site visitors. QIAGEN has no interest in, responsibility
for, or control over non-QIAGEN affiliated linked sites. QIAGEN makes
no promises or warranties of any kind, express or implied, including those
of merchantability and fitness for a particular purpose, as to content
of linked sites. In no event shall QIAGEN be liable for any damages resulting
from use of these links even if QIAGEN has been informed of the possibility
of such liability.
Differential display technology is covered by US patent No. 5,262,311
and other pending patents licensed to GenHunter Corporation.
ImmunEasy technology is covered by U.S. Patents 6,194,388 and 6,207,646
exclusively licensed by Coley Pharmaceutical Group, Inc.
The SAGE process is covered by U.S. Patent 5,695,937 owned by Genzyme
Molecular Oncology.
TAGZyme technology is licensed under U.S. Patent No. 5,691,169, U.S.
Patent No. 5,783, 413, and E.U. Patent No. 00759931B1.
Hoffmann-La Roche owns patents and patent applications pertaining to
the application of Ni-NTA resin (Patent series: RAN 4100/63: USP 4.877.830,
USP 5.047.513, EP 253 303 B1), and to 6xHis-coding vectors and His-labeled
proteins (Patent series: USP 5.284.933, USP 5.130.663, EP 282 042 B1).
All purification of recombinant proteins by Ni-NTA chromatography for
commercial purposes, and the commercial use of proteins so purified, require
a license from Hoffmann-La Roche.
The Black Hole Quenchers and BHQ dyes were developed by and licensed
from Biosearch Technologies, Novato, CA. These products are sold exclusively
for R&D use by the purchaser. They may not be used for clinical or
diagnostic purposes and they may not be re-sold, distributed or re-packaged.
Molecular Beacons are licensed under patents owned by The Public Health
Research Institute of the City of New York, Inc. and come with licensed
rights for use only in the purchaser's research and development activities.
The PAXgene Blood RNA System (cat. nos. 762105, 762115, 762331, and
762134) and the PAXgene Blood DNA System (cat. nos. 761105, 761115, 761125,
761132, and 761133) are for research use only and not for use in diagnostic
procedures.
The PAXgene Blood RNA Kit (cat. nos. 762164 and 762174) is for in vitro
diagnostic use. Not available in all countries.
The PAXgene Blood RNA MDx Kit (cat. no. 762461) is intended as a general-purpose
device for laboratory use. No claim or representation is intended for
its use to identify any specific organism or for clinical use (diagnostic,
prognostic, therapeutic, or blood banking). It is the user’s responsibility
to validate the performance of the PAXgene Blood RNA MDx Kit for any
particular use, since the performance characteristics of these kits have
not been validated for any specific organism. The performance characteristics
of this product have not been fully established.
Purchase of the QIAamp UltraSens Virus Kit is accompanied by a non-transferable,
limited license under U.S. Patents 5,674,908, 5,834,439 and 6,110,916
and foreign equivalents to use it solely for the internal research purposes
of the purchaser. Purchasers are hereby notified that neither this product,
nor any components or derivatives thereof, may be used in transfection
whereby extracellular material is conveyed into one or more cells.
QIAzol Lysis Reagent is a subject of US Patent No. 5,346,994 and foreign
equivalents.
siRNA technology is licensed to QIAGEN under European Patent 1 144 623
and foreign equivalents from Alnylam Pharmaceuticals, Inc., Cambridge,
USA and is provided only for use in academic and commercial research (excluding
the evaluation or characterization of this product as the potential basis
for a siRNA-based drug) and not for any other commercial purposes. Information
about licenses for commercial use (including discovery and development
of siRNA-based drugs) is available from Alnylam Pharmaceuticals, Inc.,
300 Third Street, Cambridge, MA 02142, USA.
siRNA technology is licensed to QIAGEN from the Massachusetts Institute
of Technology under United States Patent Application 09/821,832 and corresponding
US and foreign patent applications. siRNA technology is licensed to QIAGEN
from the Carnegie Institute of Washington under United States Patent 6,506,559
and corresponding US and foreign patent applications.
"RNAlater®" is a trademark of AMBION, Inc., Austin, Texas
and is covered by various U.S. and foreign patents.
Oregon Green and Texas Red are licensed from Molecular Probes, Inc.
Oligotex products are not available in Japan.
Strep-tag technology for protein purification and detection is covered
by US patent 5,506,121, UK patent 2272698 and French patent 93 13 066;
Strep-Tactin is covered by US patent 6,103,493.
The QIAGEN BioRobot MDx DSP workstation and QIAamp DSP kits comply with
EU Directive 98/79/EC on in vitro diagnostic medical devices. Other (non-DSP)
QIAGEN workstations and kits are intended as general-purpose devices.
No claim or representation is intended for their use to identify any specific
organism or for a specific clinical use (diagnostic, prognostic, therapeutic,
or blood banking). It is the user’s responsibility to validate the
performance of QIAGEN non-DSP workstations and kits for any particular
use, since their performance characteristics have not been validated for
any specific organism. QIAGEN non-DSP workstations and kits may be used
in clinical diagnostic laboratory systems after the laboratory has validated
their complete system as required by CLIA '88 regulations in the
U.S. or equivalents in other countries.
6x His-tag/ Ni-NTA Patent and Licensing information
QIAGEN REPLI-g Kits are for use only as licensed by Amersham Biosciences
Corp (part of GE Healthcare Bio-Sciences) and QIAGEN GmbH. The Phi 29
DNA polymerase may not be re-sold or used except in conjunction with
the other components of this kit. See U.S. Patent Nos. 5,854,033, 6,124,120,
6,143,495, 5,001,050, 5,198,543, 5,576,204, and related U.S. and foreign
patents. The REPLI-g Kit is developed, designed, and sold for research
purpose only.
Benzonase® Nuclease is manufactured by Merck KGaA and its affiliates.
The technology is covered by US Patent 5,173,418 and EP Patent 0,229,866.
Nycomed Pharma A/S (Denmark) claims worldwide patent rights to Benzonase® Nuclease,
which are licensed exclusively to Merck KGaA, Darmstadt, Germany.
The QuantiTect Whole Transcriptome Kit is for use only as licensed by Amersham Biosciences Corp (part of GE Healthcare Bio-Sciences) and QIAGEN GmbH. The Phi 29 DNA polymerase may not be re-sold or used except in conjunction with the other components of this kit. See U.S. Patent Nos. 5,854,033, 6,124,120, 6,143,495, 5,001,050, 5,198,543, 5,576,204, and related U.S. and foreign patents.
Certain specific embodiments of the process of multiplex PCR may be covered by patents of third parties in certain countries and may require a license.
SBTexcellerator HLA Kits are licensed from Genome Diagnostics BV. QIAGEN acts as a co-exclusive distributor of SBTengine software. |
| QuantiFast SYBR Green PCR Kit, QuantiTect SYBR Green PCR Kit, QuantiFast SYBR Green RT-PCR Kit, QuantiTect SYBR Green RT-PCR Kit, FastLane Cell SYBR Green Kit, and miScript SYBR Green PCR Kit |
The purchase price of this product includes a limited, non-transferable immunity from suit under U.S. Patents Nos. 5,994,056 and 6,171,785 and corresponding patent claims outside the United States, owned by Roche Molecular Systems, Inc. or F. Hoffmann-La Roche Ltd (Roche), to use only this amount of the product for dsDNA-binding dye processes covered by said patents solely for the purchaser’s own internal research. This product is also a Licensed dsDNA Dye Binding Kit for use with service sublicenses available from Applied Biosystems. No right under any other patent claims (such as apparatus or system claims in U.S. Patent No. 6,814,934) and no right to use this product for any other purpose or for commercial services of any kind, including without limitation reporting the results of purchaser’s activities for a fee or other commercial consideration, is hereby granted expressly, by implication or by estoppel. This product is for research use only. Diagnostic uses require a separate license from Roche. Further information on purchasing licenses may be obtained by contacting the Director of Licensing, Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA. |
| QuantiFast Probe PCR Kits, QuantiTect Probe PCR Kit, QuantiFast Probe RT-PCR Kits, QuantiTect Probe RT-PCR Kit, QuantiTect Multiplex PCR Kits, QuantiTect Multiplex RT-PCR Kits, QuantiTect Virus Kits, FastLane Cell Probe Kit, and FastLane Cell Multiplex Kits |
NOTICE TO PURCHASER: LIMITED LICENSE
A license to perform the 5’ nuclease process for research requires the use of a Licensed 5’ Nuclease Kit (containing Licensed Probe), or the combination of an Authorized 5’ Nuclease Core Kit plus Licensed Probe, or license rights that may be purchased from Applied Biosystems. This product is an Authorized 5’ Nuclease Core Kit without Licensed Probe. Its purchase price includes a limited, non-transferable immunity from suit under U.S. Patents Nos. 5,210,015, 5,487,972, 5,476,774, and 5,219,727, and corresponding patent claims outside the United States, owned by Roche Molecular Systems, Inc. or F. Hoffmann-La Roche Ltd (Roche), for using only this amount of the product in the practice of the 5’ nuclease process solely for the purchaser’s own internal research when used in conjunction with Licensed Probe. This product is also an Authorized 5’ Nuclease Core Kit for use with service sublicenses available from Applied Biosystems. This product conveys no rights under U.S. Patents Nos. 5,804,375, 6,214,979, 5,538,848, 5,723,591, 5,876,930, 6,030,787, or 6,258,569, or corresponding patents outside the United States, expressly, by implication or by estoppel. No right under any other patent claims (such as apparatus or system claims in U.S. Patent No. 6,814,934) and no right to perform commercial services of any kind, including without limitation reporting the results of purchaser's activities for a fee or other commercial consideration, is hereby granted expressly, by implication or by estoppel. This product is for research use only. Diagnostic uses require a separate license from Roche. Further information on purchasing licenses may be obtained by contacting the Director of Licensing, Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA. |
| QuantiFast SYBR Green RT-PCR Kit, QuantiTect SYBR Green RT-PCR Kit, QuantiFast Probe RT-PCR Kits, QuantiTect Probe RT-PCR Kit, QuantiTect Multiplex RT-PCR Kits, QuantiTect Virus Kits, FastLane Cell SYBR Green Kit, FastLane Cell Probe Kit, and FastLane Cell Multiplex Kits |
NOTICE TO PURCHASER: LIMITED LICENSE
The purchase price of this product includes a limited, non-transferable license under U.S. Patents Nos. 5,407,800, 5,322,770, 5,310,652 and corresponding patent claims outside the United States, owned by Roche Molecular Systems, Inc. or F. Hoffmann-La Roche Ltd (Roche), to use only this amount of product solely for the purchaser’s own internal research. No right under any other patent claims (such as apparatus or system claims) and no right to use this product for any other purpose or for commercial services of any kind, including without limitation reporting the results of purchaser’s activities for a fee or other commercial consideration, is hereby granted expressly, by implication or by estoppel. This product is for research use only. Diagnostic uses require a separate license from Roche. Further information on purchasing licenses may be obtained by contacting the Director of Licensing, Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA. |
| QuantiTect SYBR Green PCR Kit, QuantiTect SYBR Green RT-PCR Kit, QuantiTect Probe PCR Kit, QuantiTect Probe RT-PCR Kit, QuantiTect Multiplex PCR Kits, QuantiTect Multiplex RT-PCR Kits, FastLane Cell SYBR Green Kit, FastLane Cell Probe Kit, FastLane Cell Multiplex Kits, and miScript SYBR Green PCR Kit |
NOTICE TO PURCHASER: LIMITED LICENSE
This product or its use is covered by at least one claim of U.S. Pat. Nos. 5,035,996; 5,945,313; 6,287,823; or 6,518,026, owned by Invitrogen Corporation. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The buyer cannot sell or otherwise transfer (a) this product, (b) its components, or (c) materials made by the employment of this product or its components to a third party or otherwise use this product or its components or materials made by the employment of this product or its components for Commercial Purposes. Commercial Purposes means any activity for which a party receives or is due to receive consideration and may include, but is not limited to: (1) use of the product or its components in manufacturing; (2) use of the product or its components to provide a service, information, or data; (3) use of the product or its components for therapeutic, diagnostic or prophylactic purposes; or (4) resale of the product or its components, whether or not such product or its components are resold for use in research. The buyer cannot use this product or its components or materials made using this product or its components for therapeutic, diagnostic or prophylactic purposes. Further information on purchasing licenses under the above patents may be obtained by contacting the Licensing Department, Invitrogen Corporation, 1600 Faraday Avenue, Carlsbad, CA 92008. Email: outlicensing@invitrogen.com. |
| QuantiTect Primer Assays and miScript Primer Assays |
NOTICE TO PURCHASER: DISCLAIMER OF LICENSE
This product is compatible for use in real-time PCR methodologies, including 5’ nuclease processes and dsDNA-binding dye processes claimed in patents owned by Roche Molecular Systems, Inc., F. Hoffmann-La Roche Ltd, and Applera Corporation. No right to perform any of these patented processes is conveyed, expressly, by implication or by estoppel to the purchaser by the purchase of this product. A license to use these patented processes for the purchaser’s own internal research accompanies the purchase of certain reagents of Applied Biosystems and other licensed suppliers, or is available from Applied Biosystems. Further information on purchasing licenses may be obtained by contacting the Director of Licensing, Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA.
|
| QuantiTect Custom Assays |
Purchase of this product carries with it a limited, non-transferable, non-exclusive (without the right to resell, repackage, or sublicense) license under U.S. Patent Nos. 6,030,787; 5,723,591; and 5,876,930, and corresponding foreign patents. No other license under these patents or any other patents is granted expressly, impliedly, or by estoppel. No license under the PCR process is conveyed through purchase of this product. This limited license permits the person or legal entity to which this product has been provided to use the product, and the data generated by use of the product, only for its internal research purposes involving hybridization-based analysis of nucleic acids in the ordinary course of Buyer’s normal internal research and development activities within the life sciences field (including without limitation, drug discovery, drug development, medical research, fermentation research and agricultural research). The product may not be used for any other commercial, clinical, diagnostic or any other use, including, without limitation any human or animal diagnostic uses (including any use of the results of any testing performed with this product in making therapeutic or treatment decisions for a patient), industrial (including food industry) testing, forensic testing, environmental testing (including bio-terrorism and bio-warfare), or any use of these products to provide services of any kind.
Buyer agrees and understands it is not licensed to (a) provide commercial data or databases to or on behalf of any third party that relate to use of the product; or (b) use the product or data there from in a clinical diagnostic setting where data from an individual’s sample is given to such individual or their caregiver. Neither Nanogen nor its licensors grants any other licenses, express or implied, to permit the manufacture, use, sale, or importation of the product, any other nucleic acids, or any data generated from use of the product.
This product or portions hereof are subject to proprietary rights of Nanogen, Inc. and this product is made and sold under license from Nanogen under Nanogen’s patents and patent applications and there is no implied license for any other use with respect to this product. A license must be obtained directly from Nanogen with respect to any other proposed use of this product.
Powered by innovation from Nanogen
Manufactured for QIAGEN by Nanogen |
| Other trademarks |
| ABI PRISM®, AmpFlstr®, BigDye™, Applied Biosystems®, CDP-Star®, FAM™, Genotyper®, GeneScan®, Identifi ler®, GeneAmp®, GeneMapper®, JOE™, Primer Express®, SNaPshot™, VIC® (Applera Corporation or its subsidiaries); Affymetrix®, GeneChip® (Affymetrix, Inc.); Agilent® (Agilent Technologies, Inc.); ÄKTA®, Cy®, DYEnamic™, FPLC®, MegaBACE™ (GE Healthcare); Alexa Fluor®, SYBR® (Molecular Probes, Inc.); Benzonase® (Merck KGaA, Darmstadt, Germany); BioLogic™, iCycler iQ® (Bio-Rad Laboratories, Inc.); BioMag® (Polysciences Inc.); CEQ™ (Beckman Coulter, Inc.); Coomassie® (ICI [Imperial Chemical Industries] Organics Inc.); DACRON®, Teflon® (E. I. du Pont de Nemours and Company); DAPase™, pGAPase™, Qcyclase™, TAGZyme™ (UNIZYME); DART™, SBTexcellerator®, SBTengine®, (Genome Diagnostics); FACS® (Becton Dickinson and Company); FTA®, Whatman® (Whatman Group); LightCycler®, TaqMan® (Roche Group); Luminex®, xMAP® (Luminex Corporation); Mastercycler® (Eppendorf AG); Mx3005P®, pBluescript® (Stratagene); MGB™ (Epoch Biosciences); Nanosep® (Pall Corporation); NASBA® (Organon Teknika); Opera™ (Evotec Technologies); PAXgene® (PreAnalytiX GmbH); PreservCyt® (Cytyc Corporation); Rotor-Gene™, Rotor-Disc™, HRM™ (Corbett Research); SSP™ (Olerup SSP AB Company, Sweden); SurePath™ (TriPath Imaging, Inc.). All other trademarks are the property of their respective owners. |
| Rotor-Gene Q |
The QIAGEN silver logo is exclusively licensed to Corbett Research.
NOTICE TO PURCHASER:
The purchase of this product (Rotor-Gene Q, Rotor-Disc) includes a limited, non-transferable license to certain patents (see details below) surrounding rapid polymerase chain reaction (PCR) methods and instrumentation, the use of SYBR® Green I in PCR reactions, melting curve analysis, analysis methods of DNA melting data, specifically high resolution melting (HRM) and others.
The purchase of this product (Rotor-Gene Q, Rotor-Disc) includes a limited, non-transferable license to one or more of US Patents Nos 6,787,338; 7,238,321; 7,081,226; 6,174,670; 6,245,514; 6,569,627; 6,303,305; 6,503,720; 5,871,908; 6,691,041; 7,387,887; and U.S. Patent Applications Nos. 2003-0224434 and 2006-0019253 and all continuations and divisionals, and corresponding claims in patents and patent applications outside the United States, owned by the University of Utah Research Foundation, Idaho Technology, Inc., and/or Roche Diagnostics GmbH, for internal research use or for non-in vitro diagnostics applications. No right is conveyed, expressly, by implication or estoppel, for any reagent or kit, or under any other patent or patent claims owned by the University of Utah Research Foundation, Idaho Technology, Inc., and/or Roche Diagnostics GmbH, or by any other Party. For information on purchasing licences for in-vitro diagnostics applications or reagents, contact Roche Molecular Systems, 4300 Hacienda Drive, Pleasanton, CA 94588, USA.
ADDITIONAL NOTICE TO PURCHASER IN USA, EUROPE AND AUSTRALIA ONLY:
Practice of the polymerase chain reaction (PCR) process may require a license depending on the reagents and methods applied. Purchase of this instrument (Rotor-Gene Q) does not itself convey to the purchaser a complete license or right to perform the PCR process. The use of this instrument (Rotor- Gene Q) with Authorized Reagents such as Authorized QIAGEN kits and assays provides a limited PCR license in accordance with the label rights accompanying such reagents.
Further information on purchasing licenses to practice the PCR process may be obtained by contacting the Director of Licensing at Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA and/or Roche Molecular Systems, 4300 Hacienda Drive, Pleasanton, CA 94588, USA. No right is conveyed expressly, by implication or by estoppel under any other patent claim, such as claims to apparatus, reagents, kits, or methods such as 5' nuclease methods. |
